MediWound to Present Phase 2 EscharEx® Data at the Symposium on Advanced Wound Care (SAWC) Spring 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MediWound Announces the Appointment of Hani Luxenburg as Chief Financial Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
16.03.2023 - 2022 total revenues of $26.5 million FDA approval of NexoBrid in December 2022; U.S. commercial availability expected in the second quarter of 2023 EscharEx Phase III protocol design is under review by the FDA; study to be initiated in the second .
Appoints Barry Wolfenson, as Executive Vice President of Strategy and Corporate Development Appoints Alicia Torrenova, as Vice President of European Operations Both bring extensive leadership. | March 6, 2023